Skip to main content
. 2024 Jan 20;13(1):102. doi: 10.3390/antibiotics13010102

Table 3.

Consumption of the top 10 systemic antibiotics in the years highlighted, expressed as DDD per 100 patient-days (DHPD).

2010 2019
Group of ATC Systemic INN * DDD per
100 Patient-Days
% cum ** % Group of ATC Systemic INN * DDD per
100 Patient-Days
% cum ** %
1. J01CR02 Co-amoxiclav 5.1 23.3 23.3 J01CR02 Co-amoxiclav 4.7 20.0 20.0
2. J01MA02 Ciprofloxacin 2.8 12.9 36.2 J01DD04 Ceftriaxone 3.3 14.3 34.3
3. J01DC02 Cefuroxime 2.1 9.5 45.7 J01DC02 Cefuroxime 2.2 9.5 43.7
4. J01DD04 Ceftriaxone 1.6 7.2 52.9 J01AA02 Doxycycline 2.0 8.6 52.4
5. J01FA09 Clarithromycin 1.3 6.1 59.0 J01MA02 Ciprofloxacin 1.4 6.1 58.4
6. J01MA12 Levofloxacin 1.0 4.3 63.3 J01FA09 Clarithromycin 1.4 5.9 64.4
7. J01FF01 Clindamycin 0.9 4.0 67.3 J01MA12 Levofloxacin 1.0 4.1 68.5
8. J01FA10 Azithromycin 0.8 3.4 70.7 J01XD01 Metronidazole 0.9 3.8 72.2
9. J01EE01 Sulfamethoxazol-trimethoprim 0.7 3.2 73.9 J01DB04 Cefazolin 0.7 3.2 75.4
10. J01MA14 Moxifloxacin 0.6 2.6 76.5 J01FF01 Clindamycin 0.7 3.1 78.5
Pandemic years
2020 2021
Group of ATC Systemic INN * DDD per
100 patient-days
% cum ** % Group of ATC Systemic INN * DDD per
100 patient-days
% cum ** %
1. J01DD04 Ceftriaxone 5.9 18.2 18.2 J01DD04 Ceftriaxone 6.5 19.3 19.3
2. J01CR02 Co-amoxiclav 5.1 15.9 34.1 J01CR02 Co-amoxiclav 5.4 15.9 35.2
3. J01DC02 Cefuroxime 2.3 7.2 41.3 J01DC02 Cefuroxime 2.1 6.2 41.4
4. J01FA10 Azithromycin 2.2 7.0 48.3 J01XD01 Metronidazole 2.0 6.1 47.5
5. J01FA09 Clarithromycin 2.0 6.4 54.6 J01FA10 Azithromycin 2.0 6.0 53.5
6. J01XD01 Metronidazole 1.9 5.9 60.5 J01AA02 Doxycycline 1.8 5.2 58.7
7. J01MA12 Levofloxacin 1.5 4.8 65.3 J01FA09 Clarithromycin 1.7 5.0 63.7
8. J01MA02 Ciprofloxacin 1.5 4.6 69.9 J01MA12 Levofloxacin 1.6 4.8 68.5
9. J01AA02 Doxycycline 1.4 4.4 74.4 J01MA02 Ciprofloxacin 1.3 3.8 72.3
10. J01DH51 Imipenem +
cilastatin
1.0 3.1 77.4 J01DH51 Imipenem +
cilastatin
1.0 3.0 75.4

* INN: International Nonproprietary Names. ** cum: cumulative.